Expanding the role of blood progenitor cells Journal Article
| Author: | Pettengell, R. |
| Article Title: | Expanding the role of blood progenitor cells |
| Abstract: | Five years ago the haemopoietic growth factors were introduced to clinical practice with the aim of reducing the depth and duration of chemotherapy induced neutropenia. Now, they have a wider remit, with important roles in supporting dose intensive treatments and mobilising BPC. Similarly, BPC themselves have until now been predominantly used in autologous transplantation following myeloablative treatments. In the next five years we can expect to see BPC from novel sources manipulated to feature in many new roles, including allogeneic transplantation, multicyclic dose-intensive chemotherapy and gene therapy. © 1995 Kluwer Academic Publishers. |
| Keywords: | neutropenia; review; fluorouracil; antineoplastic agent; stem cell factor; bone marrow suppression; etoposide; granulocyte macrophage colony stimulating factor; cyclophosphamide; stem cell transplantation; transplantation; cytokine; blood cell; hematopoietic stem cell; granulocyte colony stimulating factor; hemopoietic growth factor; interleukin 3; blood progenitor cells; cancer; human; priority journal; mobilisation |
| Journal Title: | Annals of Oncology |
| Volume: | 6 |
| Issue: | 8 |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 1995-10-01 |
| Start Page: | 759 |
| End Page: | 767 |
| Language: | English |
| PUBMED: | 8589012 |
| PROVIDER: | scopus |
| DOI: | 10.1093/oxfordjournals.annonc.a059313 |
| DOI/URL: | |
| Notes: | Review -- Export Date: 28 August 2018 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work